首页> 外文OA文献 >Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

【2h】

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

机译：一项在异基因HCT后具有统一移植特征的多中心3期试验中，存在死亡风险的血浆生物标志物。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zaid, Mohammad Abu; Wu, Juan; Wu, Cindy; Logan, Brent R.; Yu, Jeffrey; Cutler, Corey; Antin, Joseph H.; Paczesny, Sophie; Choi, Sung Won;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT [J] . Abu Zaid Mohammad, Wu Juan, Wu Cindy, Blood: The Journal of the American Society of Hematology . 2017,第2期

机译：多中心相3试验中的死亡风险血浆生物标志物，具有均匀的移植特性后异构性HCT
2. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients [J] . Caballero-VelázquezT., López-CorralL., EncinasC., British Journal of Haematology . 2013,第4期

机译：高强度骨髓瘤患者在降低强度调节方案（RIC）和同种异体移植后评估硼替佐米的II期临床试验
3. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study [J] . Starling R. C., Stehlik J., Baran D. A., American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2016,第1期

机译：免疫生物标记物和心脏移植结果的多中心分析：器官移植05研究的临床试验结果
4. A multicenter efficacy trial of different vaccination strategies against Mycoplasma hyopneumonia in Europe [C] . Mark Mombarg Annual Meeting of the American Association of Swine Veterinarians . 2006

机译：不同疫苗接种策略对欧洲肺炎肺骨膜养殖的多中心疗效试验
5. Risk Factors for Death or Heart Transplant for Patients with Right Ventricular Dysfunction after the Norwood Procedure: A Secondary Analysis of the Single Ventricle Reconstruction Trial [D] . Jean-St-Michel, Emilie Melissa. 2017

机译：诺伍德过程后右心室功能障碍患者的死亡或心脏移植的危险因素：单一脑室重建试验的二次分析
6. Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post–allogeneic HCT [O] . Mohammad Abu Zaid, Juan Wu, Cindy Wu, -1

机译：在异基因HCT后具有统一移植特征的多中心3期试验中血浆死亡风险标志物
7. Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients [O] . Caballero-Velázquez Teresa, López-Corral L., Encinas Cristina, 2016

机译：高风险骨髓瘤患者在降低强度条件治疗方案（RIC）和同种异体移植后评估硼替佐米的II期临床试验

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

著录项

引文网络

相似文献

相关主题

期刊订阅